EVEREST MED.LTD DL-0001 (6HN) — Working Capital to Net Assets Ratio
EVEREST MED.LTD DL-0001 (6HN) has a Working Capital to Net Assets ratio of 42.4% as of June 2026. Working capital of €2.22 Billion (current assets of €3.02 Billion minus current liabilities of €799.93 Million) is measured against net assets of €5.23 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See operational self-sufficiency of EVEREST MED.LTD DL-0001 to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
EVEREST MED.LTD DL-0001 Working Capital to Net Assets (2021–2025)
This chart shows how EVEREST MED.LTD DL-0001's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 42.4%, reflecting working capital of €2.22 Billion against net assets of €5.23 Billion EUR. For the complete balance sheet picture, see EVEREST MED.LTD DL-0001 assets under control.
Annual Working Capital to Net Assets for EVEREST MED.LTD DL-0001 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for EVEREST MED.LTD DL-0001 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check EVEREST MED.LTD DL-0001 liquidity resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 50.6% | €2.68 Billion | €5.30 Billion | €3.37 Billion | €689.61 Million | ▲ +20.6 pp |
| 2024 | 30.0% | €1.22 Billion | €4.07 Billion | €2.02 Billion | €793.54 Million | ▼ -13.8 pp |
| 2023 | 43.9% | €2.18 Billion | €4.97 Billion | €2.51 Billion | €328.74 Million | ▼ -0.6 pp |
| 2022 | 44.4% | €2.51 Billion | €5.65 Billion | €3.41 Billion | €900.95 Million | ▲ +3.4 pp |
| 2021 | 41.0% | €2.42 Billion | €5.89 Billion | €2.69 Billion | €270.27 Million | — |